ОЦЕНКА ТЕРАПЕВТИЧЕСКОЙ ЭФФЕКТИВНОСТИ ВАРФАРИНА ПРОИЗВОДСТВА ЗАО «КАНОНФАРМА ПРАДАКШЕН» (РОССИЯ)
Warfarin by «Kanonpharma production» (Russia) and original Warfarin have the similar safety and tolerability. We need some increase of dose of Warfarin by «Kanonpharma production» to reach target rate of INR, then in case of original Warfarin usage. But for 1.5 month of treatment this characteristic...
Saved in:
| Main Authors: | М. В. Хруслов, Е. В. Ройтман |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
SINAPS LLC
2014-02-01
|
| Series: | Архивъ внутренней медицины |
| Subjects: | |
| Online Access: | https://www.medarhive.ru/jour/article/view/262 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Value of Using Bedside Point of Care Testing for International Normalized Ratio in Patients on Warfarin Undergoing Dental Procedures and Bleeding Assessment; A Single Center Prospective Study
by: Albarkheel A, et al.
Published: (2025-07-01) -
Anticoagulation therapy and related outcomes among Asian patients after bioprosthetic valve replacement
by: Tang-Yu Liu, et al.
Published: (2025-05-01) -
The impact of anti-infective therapy on patients undergoing warfarin treatment
by: Linlin Fu, et al.
Published: (2024-12-01) -
Study of target INR achievement, incidence of hemorrhagic complications and affecting factors after during warfarin treatment in western area of China
by: Rui Shi, et al.
Published: (2025-05-01) -
RANDOMIZED COMPARISON OF TWO APPROACHES TO WARFARIN DOSAGE IN CARDIOVASCULAR HOSPITAL SECTION
by: L. N. Mishchenko, et al.
Published: (2015-08-01)